Literature DB >> 22801596

Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats.

Ishwarlal Jialal1, Sridevi Devaraj.   

Abstract

OBJECTIVE: Type 1 diabetes mellitus (T1DM) is a pro-inflammatory state characterized by high C-reactive protein (CRP) levels. Previously, we showed that CRP accentuated a macrophage (MO) activity in spontaneously diabetic biobreeding (BB) rats and increased the MO activity of protein kinase C-alpha (PKC-α) and p47phox. In this report, we tested the effects of molecular inhibition of CRP effects on MO activity using antisense oligonucleotide (ASO) to both PKC-α and p47phox.
METHODS: Prior to administration of human C-reactive protein (hCRP) daily for 3 days, ASO or scrambled ASO to either PKC-α or p47phox was also delivered for 3 days and after killing on day 4, peritoneal MOs were isolated.
RESULTS: The increase in the levels of superoxide anion, interleukin (IL)-1, monocyte chemoattractant protein-1 (MCP-1), tumour necrosis factor-alpha (TNF-α) and IL-6 release in MOs with hCRP compared to human albumin was significantly attenuated by antisense to either PKC-α and p47phox (p < 0.01 vs. scrambled ASO; n = 5 per group).
CONCLUSION: Our novel data suggest that antisense to either PKC-α or p47phox attenuates the pro-inflammatory effects of human CRP on MOs in diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801596      PMCID: PMC3523880          DOI: 10.1177/1479164112452165

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  20 in total

1.  Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

Authors:  C G Schalkwijk; D C Poland; W van Dijk; A Kok; J J Emeis; A M Dräger; A Doni; V W van Hinsbergh; C D Stehouwer
Journal:  Diabetologia       Date:  1999-03       Impact factor: 10.122

2.  Diabetes is a proinflammatory state: a translational perspective.

Authors:  Sridevi Devaraj; Mohan R Dasu; Ishwarlal Jialal
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

3.  High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.

Authors:  J Sundell; T Rönnemaa; H Laine; O T Raitakari; M Luotolahti; P Nuutila; J Knuuti
Journal:  Diabetologia       Date:  2004-11-24       Impact factor: 10.122

4.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

5.  Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes.

Authors:  Rieko Hayaishi-Okano; Yoshimitsu Yamasaki; Naoto Katakami; Kentaro Ohtoshi; Shin-Ichi Gorogawa; Akio Kuroda; Munehide Matsuhisa; Keisuke Kosugi; Norikiyo Nishikawa; Yoshitaka Kajimoto; Masatsugu Hori
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

Review 6.  The evolving role of C-reactive protein in atherothrombosis.

Authors:  Sridevi Devaraj; Uma Singh; Ishwarlal Jialal
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

7.  C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo.

Authors:  Sridevi Devaraj; Mohan R Dasu; Uma Singh; L Vijaya Mohan Rao; Ishwarlal Jialal
Journal:  Atherosclerosis       Date:  2008-06-13       Impact factor: 5.162

8.  Definition of a C-reactive protein binding determinant on histones.

Authors:  T W Du Clos; L T Zlock; L Marnell
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

9.  Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications.

Authors:  Sridevi Devaraj; Anthony T Cheung; Ishwarlal Jialal; Steven C Griffen; Danh Nguyen; Nicole Glaser; Thomas Aoki
Journal:  Diabetes       Date:  2007-08-08       Impact factor: 9.461

10.  High glucose induces IL-1beta expression in human monocytes: mechanistic insights.

Authors:  Mohan R Dasu; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-04-10       Impact factor: 4.310

View more
  2 in total

1.  Prenatal dexamethasone exposure in rats results in long-term epigenetic histone modifications and tumour necrosis factor-α production decrease.

Authors:  Hong-Ren Yu; Ho-Chang Kuo; Chih-Cheng Chen; Jiunn-Ming Sheen; Mao-Meng Tiao; Yu-Chieh Chen; Kow-Aung Chang; You-Lin Tain; Li-Tung Huang
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

Review 2.  Current siRNA targets in atherosclerosis and aortic aneurysm.

Authors:  Leena Pradhan-Nabzdyk; Chenyu Huang; Frank W LoGerfo; Christoph S Nabzdyk
Journal:  Discov Med       Date:  2014-05       Impact factor: 2.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.